Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Apr 1995, 878-884, Vol 33, No. 4
JM Pinon, F Foudrinier, G Mougeot, C Marx, D Aubert, O Toupance, G Niel, M Danis, P Camerlynck and G Remy
To determine their prognostic and diagnostic values for toxoplasmosis in
immunodepressed subjects, we assayed immunoglobulin A (IgA) and IgE
antibodies by means of immunocapture (IC) tests, with revelation done by
using a suspension of T. gondii (ICT). We also carried out a simultaneous
analytical study of IgG antibodies on cellulose acetate membranes by using
the comparative immunological profile method and an enzyme-linked
immunofiltration assay (ELIFA). A total of 1,238 samples (serum,
cerebrospinal fluid, and aqueous humor from 318 patients) were tested. IgA
and IgE antibodies were detected in all heart, kidney, and liver transplant
recipients with clinical manifestations of toxoplasmosis; IgA was detected
in the aqueous humor of a patient with chorioretinitis. In patients with
AIDS-related toxoplasmosis, including the cerebral form, IgA and IgE
antibodies or a significant modification of ELIFA IgG values were observed
in 38, 19, and 25% of patients, respectively. IgM was detected by ICT only
in 12% of patients and aided the diagnosis in 1 of 71 patients. IC tests
for specific IgA and IgE alone and combined with ELIFA were positive in 39
and 46% of patients who developed clinical toxoplasmosis, respectively. In
a serial study of 16 patients in whom at least one of these three tests was
positive, a significant immunological signal sometimes preceded clinical
onset by 1, 6, and even 17 months. Similarly, in a group of human
immunodeficiency virus-infected patients with evidence of previous exposure
to T. gondii but no clinical manifestations, IgA, IgE, and IgA and/or IgE
antibodies were detected in only 11, 4, and 12% of patients,
respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Evaluation of risk and diagnostic value of quantitative assays for anti- Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients
Laboratoire de Parasitologie, Eq 5 Institut National de la Sante et de la Recherche Medicale (Unite 314), Reims, France.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|